Napin Karnchanachari

ORCID: 0000-0003-2816-8983
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Clinical practice guidelines implementation
  • Inflammatory mediators and NSAID effects
  • Economic and Financial Impacts of Cancer
  • Lung Cancer Diagnosis and Treatment
  • Pharmaceutical industry and healthcare
  • Lung Cancer Treatments and Mutations
  • Colorectal Cancer Screening and Detection
  • Patient-Provider Communication in Healthcare
  • Health Systems, Economic Evaluations, Quality of Life
  • Advances in Oncology and Radiotherapy
  • Liver Disease Diagnosis and Treatment
  • Consumer Attitudes and Food Labeling
  • Mental Health and Patient Involvement
  • Genetic factors in colorectal cancer
  • Nutrition, Genetics, and Disease
  • Lipoproteins and Cardiovascular Health
  • Obesity and Health Practices
  • Pancreatic and Hepatic Oncology Research
  • Primary Care and Health Outcomes
  • Head and Neck Cancer Studies
  • Social Media in Health Education
  • Diversity and Career in Medicine
  • Sex and Gender in Healthcare
  • Antiplatelet Therapy and Cardiovascular Diseases

The University of Melbourne
2021-2024

Primary Care Collaborative Clinical Trials Group
2022-2023

Cancer Clinic
2023

Victorian Comprehensive Cancer Centre
2022

A risk-stratified approach to colorectal cancer (CRC) screening could result in a more acceptable balance of benefits and harms, be cost-effective.To determine the effect consultation general practice using computerised risk assessment decision support tool (Colorectal RISk Prediction, CRISP) on risk-appropriate CRC screening.Randomised controlled trial 10 practices Melbourne, Australia, from May 2017 2018.Participants were recruited consecutive sample patients aged 50-74 years attending...

10.3399/bjgp.2022.0480 article EN cc-by British Journal of General Practice 2023-01-23

Objectives Australian guidelines recommend all adults aged 50–70 years old without existing contraindications consider taking low-dose aspirin (100–300 mg per day) for at least 2.5 to reduce their risk of developing colorectal cancer. We aimed explore clinicians’ practices, knowledge, opinions, and barriers facilitators the implementation these new guidelines. Methods Semistructured interviews were conducted with clinicians whom may be applicable (Familial Cancer Clinic staff (geneticists,...

10.1136/bmjopen-2020-042261 article EN cc-by-nc BMJ Open 2021-02-01

Australian guidelines recommend that all people aged 50-70 years old actively consider taking daily low-dose aspirin (100-300 mg per day) for 2.5 to 5 reduce their risk of colorectal cancer (CRC). Despite the change national CRC prevention guidelines, there has been no active implementation into clinical practice. We aim test efficacy a health consultation and decision aid, using novel expected frequency tree (EFT) present benefits harms low dose prior general practice with patients years,...

10.1186/s13063-021-05365-8 article EN cc-by Trials 2021-07-15

Background Australian guidelines recommend that people aged 50–70 years consider taking low-dose aspirin to reduce their risk of colorectal cancer (CRC). Aim To determine the effect a consultation with researcher before an appointment in general practice using decision aid presenting benefits and harms compared CRC prevention brochure on patients’ informed making use. Design setting Individually randomised controlled trial six practices Victoria, Australia, from October 2020 March 2021....

10.3399/bjgp.2023.0385 article EN cc-by British Journal of General Practice 2024-03-25

Abstract Objectives Australian guidelines recommend people aged 50–70 years old consider taking low-dose aspirin to reduce their risk of colorectal cancer. The aim was design sex-specific decision aids (DAs) with clinician and consumer input, including expected frequency trees (EFTs) communicate the risks benefits aspirin. Methods Semi-structured interviews were conducted clinicians. Focus groups consumers. interview schedules covered ease comprehension, design, potential effects on...

10.1093/fampra/cmad042 article EN cc-by Family Practice 2023-04-14

There is limited evidence on the development of pancreatic and oesophagogastric cancer, how patients decide to seek help factors impacting help-seeking. Our study, first in Australia, aimed explore symptom appraisal diagnostic pathways these patients. A secondary aim was examine potential recruit cancer through a quality registry.Patients diagnosed with or were recruited Monash University's Upper-Gastrointestinal Cancer Registry. Data collected general practitioners (GP) patient...

10.1111/ecc.13605 article EN European Journal of Cancer Care 2022-05-06

Background General practice plays a critical role in the prevention, diagnosis, management, and survivorship care of patients with cancer. Mapping research outputs over time provides valuable insights into evolving general cancer care. Aim To describe compare distribution publications by country, type, area continuum, author sex, journal impact factor. Design setting A bibliometric analysis using systematic approach to identify publications. Method MEDLINE Embase databases were searched for...

10.3399/bjgp.2022.0025 article EN cc-by British Journal of General Practice 2022-09-21

Abstract Background : Australian guidelines recommend that all people aged 50-70 years old actively consider taking daily low-dose aspirin (100–300mg per day) for 2.5 to 5 reduce their risk of colorectal cancer (CRC). Despite the change national CRC prevention guidelines, there has been no active implementation into clinical practice. We aim test efficacy a health consultation and decision aid, using novel expected frequency tree (EFT) present benefits harms low dose prior general practice...

10.21203/rs.3.rs-406678/v1 preprint EN cc-by Research Square (Research Square) 2021-05-10

Australian guidelines recommend 50-70 years consider taking aspirin to reduce their bowel cancer risk. We trialled a decision aid in general practice facilitate the implementation of these into clinical practice. This publication reports on qualitative results from process evaluation trial. aimed explore practitioners' (GPs) and patients' approach shared decision-making (SDM) about prevent how aids were used Semistructured interviews conducted with 17 participants who received 12 GPs...

10.1136/fmch-2023-002423 article EN cc-by-nc Family Medicine and Community Health 2023-11-01

Abstract Objectives Australian guidelines recommend people aged 50 to 70-years-old, consider taking low-dose aspirin reduce their risk of colorectal cancer. The aim was design sex-specific decision aids (DAs) with clinician and consumer input including expected frequency trees (EFTs) communicate risks benefits aspirin. Methods Semi-structured interviews were conducted clinicians. Focus groups consumers. interview schedules covered ease comprehension, design, potential effects on making,...

10.21203/rs.3.rs-1759039/v1 preprint EN cc-by Research Square (Research Square) 2022-06-15

Abstract Objectives Australian guidelines recommend people aged 50 to 70-years-old, consider taking low-dose aspirin reduce their risk of colorectal cancer. The aim was design sex-specific decision aids (DAs) with clinician and consumer input including expected frequency trees (EFTs) communicate risks benefits aspirin. Methods Semi-structured interviews were conducted clinicians. Focus groups consumers. interview schedules covered ease comprehension, design, potential effects on making,...

10.21203/rs.3.rs-1759039/v2 preprint EN cc-by Research Square (Research Square) 2022-06-16

BACKGROUND: Australian guidelines recommend that all people aged 50-70 years old actively consider taking daily low-dose aspirin (100-300 mg per day) for 2.5 to 5 years reduce their risk of colorectal cancer (CRC). Despite the change national CRC prevention guidelines, there has been no active implementation into clinical practice. We aim test efficacy a health consultation and decision aid, using novel expected frequency tree (EFT) present benefits harms low dose prior general practice with...

10.17863/cam.74294 article EN 2021-07-15
Coming Soon ...